SAR 90.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 250.11 Million | 176.05 Million | 131.25 Million | 74.41 Million |
Cost of Revenue | 143.6 Million | 95.47 Million | 66.71 Million | 36.53 Million |
Gross Profit | 106.5 Million | 80.57 Million | 64.53 Million | 37.88 Million |
Operating Expenses | 73.16 Million | 54.56 Million | 40.08 Million | 26.23 Million |
Selling, General and Administrative Expenses | 73.16 Million | 54.56 Million | 40.08 Million | 26.23 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | - | -401.26 Thousand | - | - |
Cost and Expenses | 216.77 Million | 150.04 Million | 106.8 Million | 62.76 Million |
Operating Income | 33.34 Million | 26 Million | 24.45 Million | 11.64 Million |
Interest Expense | 6.92 Million | 4.74 Million | 2.56 Million | 1.31 Million |
Income Tax Expense | 2.37 Million | 1.85 Million | 1.19 Million | 707.57 Thousand |
Earnings before Tax | 27.21 Million | 20.86 Million | 21.81 Million | 10 Million |
Net Income | 24.84 Million | 19.01 Million | 20.61 Million | 9.29 Million |
Earnings Per Share Basic | 7.10 | 5.43 | 5.89 | 2.66 |
Earnings Per Share Diluted | 7.10 | 5.43 | 5.89 | 2.66 |
Weighted Average Shares Outstanding | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million |
Weighted Average Shares Outstanding (Diluted) | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million |
Gross Margin | 0.43 | 0.46 | 0.49 | 0.51 |
EBIT Margin | 0.16 | 0.17 | 0.20 | 0.18 |
Profit Margin | 0.10 | 0.11 | 0.16 | 0.12 |
EBITDA | 39.31 Million | 28.56 Million | 26.74 Million | 13.23 Million |
Earnings Before Tax Margin | 0.13 | 0.15 | 0.19 | 0.16 |
Breakdown | 2023 FY | 2022 FY | 2022 Q4 | 2021 FY | 2021 Q4 | 2020 FY |
---|---|---|---|---|---|---|
Revenue | 250.11 Million | 176.05 Million | 58.45 Million | 131.25 Million | 50.12 Million | 74.41 Million |
Cost of Revenue | 143.6 Million | 95.47 Million | 28.73 Million | 66.71 Million | 25.7 Million | 36.53 Million |
Gross Profit | 106.5 Million | 80.57 Million | 29.71 Million | 64.53 Million | 24.41 Million | 37.88 Million |
Operating Expenses | 73.16 Million | 54.56 Million | 15.92 Million | 40.08 Million | 12.5 Million | 26.23 Million |
Selling, General and Administrative Expenses | - | - | 15.92 Million | - | 12.5 Million | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 799.47 Thousand | -401.26 Thousand | - | - | - | - |
Cost and Expenses | 216.77 Million | 150.04 Million | 44.65 Million | 106.8 Million | 38.21 Million | 62.76 Million |
Operating Income | 33.34 Million | 26 Million | 13.79 Million | 24.45 Million | 11.9 Million | 11.64 Million |
Interest Expense | 6.92 Million | 4.74 Million | 1.33 Million | 2.56 Million | 236.32 Thousand | 1.31 Million |
Income Tax Expense | 2.37 Million | 1.85 Million | 560.44 Thousand | 1.19 Million | 297.83 Thousand | 707.57 Thousand |
Earnings before Tax | 27.21 Million | 20.86 Million | 12.43 Million | 21.81 Million | 11.72 Million | 10 Million |
Net Income | 24.84 Million | 19.01 Million | 11.87 Million | 20.61 Million | 11.42 Million | 9.29 Million |
Earnings Per Share Basic | - | - | 3.39 | - | 3.26 | - |
Earnings Per Share Diluted | - | - | 3.39 | - | 3.26 | - |
Weighted Average Shares Outstanding | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million |
Weighted Average Shares Outstanding (Diluted) | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million | 3.5 Million |
Gross Margin | 0.43 | 0.46 | 0.51 | 0.49 | 0.49 | 0.51 |
EBIT Margin | - | - | 0.25 | - | 0.25 | - |
Profit Margin | 0.10 | 0.11 | 0.20 | 0.16 | 0.23 | 0.12 |
EBITDA | - | - | 14.64 Million | - | 12.58 Million | - |
Earnings Before Tax Margin | 0.13 | 0.15 | 0.24 | 0.19 | 0.24 | 0.16 |
CRHKF
1300
KEY
GLEN
MLBEF
BIO